Web Analytics


Our publications:
Our publications

India Business Law Journal - November 2013

Volume 7, Issue 5

If you are a subscriber, please sign in below.

You must be a subscribersubscribersubscribersubscriber to read this content, please subscribesubscribesubscribesubscribe today.

For group subscribers, please click here to access.
Interested in group subscription? Please contact us.

你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章,欢迎成为我们的订阅会员成为我们的订阅会员

已有集团订阅,可点击此处继续浏览。
如对集团订阅感兴趣,请联络我们

Highlights:

In this issue

Cellular ambition

Medical negligence: A hypocritical oath?

By Vivek Vashi and Shreya Gupta, Bharucha & Partners

Credit where credit’s due

India’s external commercial borrowing guidelines could do more to help borrowers obtain indirect financing from export credit agencies

Deepak Sriniwas of Lex Orbis

Compulsory licensing: round two

The recent rejection of an application to produce a generic version of a patented drug shows India is following the rules

Doing business in Canada: Commercial real estate

By Simon Crawford, Bennett Jones LLP

Infrastructure revolution offering huge opportunities

By Gautam Khaitan and Nidhi Mathur, OP Khaitan & Co
By Manoj K Singh, Singh & Associates, Advocates & Solicitors

Recent judicial approach to the hot news doctrine

By Manoj K Singh, Singh & Associates, Advocates & Solicitors

IP mind games

As foreign companies enforce their IP rights more aggressively in India, Indian companies are coming under attack

Legal Process Outsourcing Awards 2013

As clients continue to demand more for less, India Business Law Journal reveals five LPOs that stand out from the crowd

Politicization of patents not a new development

By Richa Pandey, Krishna & Saurastri Associates

Rising to the challenge

Indian LPO providers need to change their ways to maintain their position in the evolving legal market

Trademark litigation in India

Meenu Maheswary and Omesh Puri of Lex Orbis explain why the use of a mark is key in establishing and retaining a proprietor’s rights

Wrongful ‘gift’ will truly be expensive for companies

By R Sudhinder and Mihir Kamdar, Udwadia Udeshi & Argus Partners
A photo of Ganesh Prasad and Sharad Moudgal

Enforceability of options clarified

By Ganesh Prasad and Sharad Moudgal, Khaitan & Co
By R Sudhinder and Mihir Kamdar, Udwadia Udeshi & Argus Partners

A perspective on the single economic entity concept

By R Sudhinder and Mihir Kamdar, Udwadia Udeshi & Argus Partners
By Pankaj Agarwal, Hrishikesh Waghela and Amit Kumar, Amarchand Mangaldas

Put and call options are an option now

By Pankaj Agarwal, Hrishikesh Waghela and Amit Kumar, Amarchand Mangaldas
By Siddharth Hariani and Aditya Bhargava, Phoenix Legal

A look at SEBI notification allowing contractual rights

By Siddharth Hariani and Aditya Bhargava, Phoenix Legal

The renaissance of real estate investment trusts

By Ranjana Roy Gawai and Vasudha Sen, RRG & Associates

Does promoters’ share sale result in business income?

By Pranay Bhatia and Vidushi Maheshwari, Economic Laws Practice

Drug patent trends in India

Patients everywhere would benefit from top-down reform to align India’s patent law with global norms

Follow us on WhatsApp for latest updates

Follow now